Tekla Capital Management LLC

Tekla Capital Management LLC is an investment management firm based out of Boston, Massachusetts. The company was originally established in 1986 and is currently headed by Dr. Daniel R. Omstead who acts as the CEO, CFO, and president of the company. Tekla Capital Management conducts its research internally and invests in the public equity market on a global scale, allocating its assets in the “growth equities, both public and private, debt and pooled investment vehicles, in the healthcare and life sciences industries.” The company, which was previously known as Hambrecht & Quist Capital Management, LLC, now operates with 13 employees of which 9 are investment professionals. Tekla Capital Management invests almost exclusively in the health care sector, which alone makes up well over three quarters of its total asset allocations, and also invests in the materials, information technology, and other sectors, in order of decreasing allocation. The company holds its allocations an average of 6.12 quarters and keeps its top 10 holdings an average of 11 quarters. In the most recent quarter, Tekla Capital Management had a turnover rate of approximately 43.3%. The company currently oversees over $3.3 billion in total assets under management spread across 4 total accounts, all of which are discretionary. Both of Tekla Capital Management’s total number of accounts and total assets under management have increased in recent years, with its total number of accounts doubling since just two years ago and its total managed assets experiencing significantly growth, increasing from just over $500 million back in 2010 to well over six times that amount today. Tekla Capital Management currently caters exclusively to investment companies and takes advisory fees in the form of a percentage of assets. The company is currently the investment advisory for four equity funds, all of which are closed ended funds: Tekla Helathcare Investors, Tekla Life Science Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund.